Importation of plasma and use of apheresis platelets as risk reduction measures for variant Creutzfeldt-Jakob Disease – Advisory Committee on the Safety of Blood, Tissues and Organs (SaBTO) Paediatric Components Working Group (PCWG)

Report from SaBTO’s Paediatric Components Working Group looking at whether scientific evidence supports updating specific vCJD risk reduction measures.  This document reports on the findings of the Advisory Committee on the Safety of Blood, Tissues and Organs (SaBTO) Paediatric Components Working

RightCare: Progressive Neurological Conditions Toolkit – NHS RightCare

People with progressive neurological conditions are experiencing delays in diagnosis and treatment, fragmented and uncoordinated services, limited availability of neurospecialist rehab and reablement and a lack of psycho-social support. This NHS RightCare toolkit provides expert practical advice and guidance on

Guidance on the use of cannabis‐based products for medicinal use in children and young people with epilepsy – British Paediatric Neurology Association

Interim clinical guidance for clinicians in the use and prescription of cannabis‐based products for medicinal use in children and young people with epilepsy. The BPNA has been asked to highlight the key questions specialist clinicians should address before considering prescribing

Transforming elective care services neurology: Learning from the Elective Care Development Collaborative – NHS England

This handbook is for commissioners, providers and those leading the local transformation of neurology elective care services. It describes what local health and care systems can do to transform neurology elective care services at pace, why this is necessary and

Neuro patience: still waiting for improvements in treatment and care – The Neurological Alliance

Neurological Alliance report presenting the findings of the 2018/19 National Neurology Patient Experience Survey. The report covers three main themes – accessible, personalised and holistic care and support (which includes social care, mental health and financial security). Overall, the 2018/19

Neuropad for detecting preclinical diabetic peripheral neuropathy: Medical technologies guidance [MTG38] – NICE

The case for adopting Neuropad to detect preclinical diabetic peripheral neuropathy is not supported by the evidence. Neuropad detects sub-normal sweating in patients with diabetes but the clinical importance of this in current NHS care pathways is poorly defined. There

The Vest for delivering high-frequency chest wall oscillation in people with complex neurological needs: Medtech innovation briefing [MIB159] – NICE

The technology described in this briefing is The Vest. It is intended to deliver high-frequency chest wall oscillation for clearing airways. The focus of this briefing is its use in adults and children with complex neurological needs, such as cerebral palsy and

Children with long-term conditions in the North West: Emergency hospital admissions for asthma, diabetes and epilepsy 2008/09 – Liverpool John Moores University Centre for Public Health

The North West has the highest child emergency hospital admission rate for both asthma and epilepsy and the second highest admission rate for diabetes in England. This report details child emergency hospital admission rates, emergency bed day rates and average

Lutetium (177Lu) oxodotreotide for treating unresectable or metastatic neuroendocrine tumours: Technology appraisal guidance [TA539] – NICE

Evidence-based recommendations on lutetium (177Lu) oxodotreotide (Lutathera) for treating unresectable or metastatic neuroendocrine tumours in adults. Lutetium (177Lu) oxodotreotide is recommended, within its marketing authorisation, as an option for treating unresectable or metastatic, progressive, well-differentiated (grade 1 or grade 2), somatostatin receptor-positive